CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
-13.5%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$85.8M
AUM Growth
+$85.8M
(-2.6%)
Cap. Flow
+$11.9M
Cap. Flow
% of AUM
13.89%
Top 10 Holdings %
Top 10 Hldgs %
89.92%
Holding
42
New
11
Increased
20
Reduced
2
Closed
3
Top Buys
Top Sells
| 1 |
Alerian MLP ETF
AMLP
|
$4.53M |
| 2 |
MEI Pharma
MEIP
|
$2.11M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$244K |
| 4 |
Marker Therapeutics
MRKR
|
$189K |
| 5 |
KALA BIO
KALA
|
$79.6K |
Sector Composition
| 1 | Healthcare | 66.09% |
| 2 | Financials | 4.72% |
| 3 | Consumer Discretionary | 1.11% |
| 4 | Industrials | 1.09% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Calumet Specialty Products
CLMT
$1.41B
| $239K | 0.27% |
+65,689
| New | +$239K |
|
27
Credit Acceptance
CACC
$5.78B
| $238K | 0.27% |
517
+38
| +8% | +$17.5K |
|
28
Expedia Group
EXPE
$26.6B
| $237K | 0.27% |
1,763
+141
| +9% | +$19K |
|
29
Lennar Class A
LEN
$34.5B
| $229K | 0.26% |
+4,104
| New | +$229K |
|
30
Liberty Media Series C
FWONK
$25B
| $224K | 0.25% |
+5,386
| New | +$224K |
|
31
Interactive Brokers
IBKR
$27.7B
| $220K | 0.25% |
4,098
+395
| +11% | +$21.2K |
|
32
JPMorgan Chase
JPM
$829B
| $218K | 0.25% |
+1,853
| New | +$218K |
|
33
RTX Corp
RTX
$212B
| $216K | 0.24% |
+1,583
| New | +$216K |
|
34
Citigroup
C
$178B
| $214K | 0.24% |
+3,101
| New | +$214K |
|
35
Union Pacific
UNP
$133B
| $209K | 0.24% |
+1,289
| New | +$209K |
|
36
General Motors
GM
$55.8B
| $208K | 0.23% |
+5,545
| New | +$208K |
|
37
FerroAtlántica
GSM
$780M
| $148K | 0.17% |
131,378
+130
| +0.1% | +$146 |
|
|
CBIO
38
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $115K | 0.13% |
+26,575
| New | +$115K |
|
|
FSTX
39
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $82K | 0.09% |
23,875
+54
| +0.2% | +$185 |
|
|
40
Alerian MLP ETF
AMLP
$10.7B
| – | – |
-459,744
| Closed | -$4.53M |
|
|
41
Marker Therapeutics
MRKR
$12M
| – | – |
-23,915
| Closed | -$189K |
|
|
DRNA
42
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-15,487
| Closed | -$244K |
|